Mahony Susan's Form 4 filing
Axsome Therapeutics, Inc. (AXSM) · filed Jun 10, 2026
- Accession no.
- 0001193125-26-266435
- Filed
- Jun 10, 2026
- Trade date
- Jun 8-10, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $145.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahony SusanCIK 0001463321 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | Common Stock | MOption exerciseAcquired | +1,429 | –F1 | – | 1,429 | Direct | |
| Jun 9, 2026 | Common Stock | SSaleDisposed | −300 | $237.21 | −$71,163 | 1,129 | Direct | |
| Jun 10, 2026 | Common Stock | SSaleDisposed | −300 | $246.18 | −$73,854 | 829 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | Common Stock | MOption exerciseDisposed | −1,429 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
Referenced by the price of 1 transaction in Table I.